Open AccessDo Neurobiological Understandings of Smoking Influence Quitting Self-Efficacy or Treatment Intentions?
Author(s) -
Kylie Morphett,
Adrian Carter,
Wayne Hall,
Jayne Lucke,
Brad Partridge,
Coral Gartner
Publication year - 2017
Publication title -
nicotine and tobacco research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 113
eISSN - 1469-994X
pISSN - 1462-2203
DOI - 10.1093/ntr/ntx144
Subject(s) - addiction , brain disease , smoking cessation , nicotine , medicine , logistic regression , disease , neurochemistry , clinical psychology , psychiatry , psychology , neurology , pathology
Addiction is increasingly defined as a "brain disease" caused by changes to neurochemistry. While nicotine addiction has historically been excluded in the brain disease model of addiction (BDMA), it is beginning to be labeled a chronic brain disease. We investigated whether Australian smokers endorse brain-based explanations of smoking, and whether these beliefs are associated with quitting self-efficacy or treatment intentions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom